Loading...
Viatris Inc.
VTRS•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.96
$0.06(0.73%)
Viatris Inc. (VTRS) Financial Performance & Statements
Review Viatris Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-4.46%
↓ 4.46%
Operating Income Growth
-98.68%
↓ 98.68%
Net Income Growth
-1259.41%
↓ 1259.41%
Operating Cash Flow Growth
-17.74%
↓ 17.74%
Operating Margin
-21.48%
↓ 21.48%
Gross Margin
37.22%
↑ 37.22%
Net Profit Margin
-26.47%
↓ 26.47%
ROE
-20.60%
↓ 20.60%
ROIC
-9.39%
↓ 9.39%
Viatris Inc. (VTRS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Viatris Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.53B | $3.74B | $3.80B | $3.66B |
| Cost of Revenue | $2.31B | $2.28B | $2.30B | $2.16B |
| Gross Profit | $1.22B | $1.46B | $1.49B | $1.50B |
| Gross Profit Ratio | $0.34 | $0.39 | $0.39 | $0.41 |
| R&D Expenses | $214.30M | $198.40M | $196.30M | $199.70M |
| SG&A Expenses | $1.05B | $1.003B | $928.90M | $1.02B |
| Operating Expenses | $1.39B | $1.23B | $1.73B | $1.22B |
| Total Costs & Expenses | $4.06B | $3.51B | $4.04B | $3.38B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $120.20M | $145.60M | $145.80M | $138.40M |
| Depreciation & Amortization | $746.20M | $669.70M | $786.30M | $691.00M |
| EBITDA | $342.20M | $905.80M | $541.30M | $1.13B |
| EBITDA Ratio | $0.10 | $0.24 | $0.14 | $0.31 |
| Operating Income | -$179.80M | $225.90M | -$239.90M | $203.90M |
| Operating Income Ratio | -$0.05 | $0.06 | -$0.06 | $0.06 |
| Other Income/Expenses (Net) | -$346.70M | -$135.40M | -$151.90M | $700000.00 |
| Income Before Tax | -$526.50M | $90.50M | -$391.80M | $204.60M |
| Income Before Tax Ratio | -$0.15 | $0.02 | -$0.10 | $0.06 |
| Income Tax Expense | -$10.00M | -$4.30M | $65.40M | $90.70M |
| Net Income | -$516.50M | $94.80M | -$326.40M | $113.90M |
| Net Income Ratio | -$0.15 | $0.03 | -$0.09 | $0.03 |
| EPS | -$0.43 | $0.08 | -$0.27 | $0.10 |
| Diluted EPS | -$0.43 | $0.08 | -$0.27 | $0.09 |
| Weighted Avg Shares Outstanding | $1.19B | $1.19B | $1.19B | $1.20B |
| Weighted Avg Shares Outstanding (Diluted) | $1.19B | $1.20B | $1.19B | $1.21B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan